France bans smoking in parks and on beaches
Smoking has been banned in parks, on beaches and outside schools in France to try to protect children.The ban has come into place just a week before schools in the country break for the summer holidays.It also stops people from smoking in public gardens, in bus stops and in sports venues.Catherine Vautrin, who is the Health and Family Minister in France, said, "tobacco must disappear from places where there are children".
The ban doesn't apply to electronic cigarettes like vapes.Single-use vapes were banned in the UK in June - something which was also brought in to protect children's health. Yves Martinet is the president of the National Committee Against Smoking. He said the ban is a "step in the right direction" but doesn't go far enough.He felt that e-cigarettes should have been included, saying that their flavours are used to "hook young people".
The new rules do not apply to the terraces outside of restaurants and bars.But they do stop people smoking within 10 metres of schools, swimming pools and libraries.Catherine Vautrin said the move was part of the country's aim of a "tobacco-free generation" by the year 2032.She said the areas covered by the ban are "places to play, learn, and breathe," not places for smoking.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
an hour ago
- Daily Mail
Mother tells inquest how she watched her toddler son die from sepsis after he was admitted to hospital twice in just 36 hours
A mother has described watching her young son die in front of her eyes from sepsis after being admitted to hospital twice within 36 hours, an inquest heard. Theo Tuikubulau had been gradually getting sicker and sicker with a high temperature, flu-like symptoms and was reluctant to drink or eat. Devon Coroner's Court heard the three-year-old was admitted to Derriford Hospital in Plymouth on the afternoon of July 6 2022, but discharged from the children's assessment unit shortly after midnight. He was then re-admitted to the hospital just after midnight on July 8 where he died a few hours later. Theo's mother Kayleigh Kenneford told the court she and Theo's father, Royal Navy serviceman Joe Tuikubulau, had to watch medics try and save his life. 'A lot of people came running in for the emergency and I ran out screaming,' she said. 'It's so hard knowing that your child is being worked on, and they are trying to save him. I tried to go back into the room, but they wouldn't let me. I went back outside, and I was sick. 'Joe then arrived and asked where Theo was. Joe ran in and straight back out shouting, 'No, no'. 'They were working on Theo at the time. 'The same doctor who discharged Theo on the previous admissions came into the room to speak with us. 'He said that they were going to keep trying to work on Theo and to save him. 'A little while later, that same doctor came in and said they couldn't do anymore for Theo and asked if we wanted to come and hold his hand. 'We went back into the room where Theo was and held his hand while they switched everything off.' In her witness statement, Ms Kenneford, from Plymouth, described her son's illness in the last 48 hours of his life. She said he had been feeling unwell on July 5 with what she thought was a cold and he also had a temperature. The next day he was still unwell and was not taking fluids or going to the toilet and his mother noticed a rash on his stomach. 'I wondered if it was a heat rash or something for a minute, but while I was looking into him, I saw that the side of his lip had gone a little blue,' she said. 'At one point, I checked his temperature and it was 40.2C. His breathing had deteriorated. I could see his belly going in and out quite quickly and he seemed to be gasping. 'At this point, I started to worry more and decided to call an ambulance.' Theo was admitted to Derriford Hospital on the afternoon July 6 where it was thought he had an upper respiratory infection, and he was admitted to the children's assessment unit. 'I was a worried mum,' Ms Kenneford said. 'At 10.16pm, Theo was asleep in the hospital bed. Nurses came to do his observations and then the doctor came around, a different doctor to the previous one. 'He shone a light in Theo's eyes and looked in his ears. The doctor said that Theo had an ear infection. 'The doctor suggested that it was just an ear infection and that he was happy to send Theo home. 'I asked about antibiotics, and he said that antibiotics wouldn't clear it up and it would clear up on its own. This was different to what the A&E doctor had said. 'He said they wouldn't swab him because the infection he had was too close to Covid-19 or something. I wonder now if Strep A would have shown up if they had swabbed him?' They were sent home at 12.30am on July 7, and Ms Kenneford told the hearing: 'I felt okay because I believed what the professionals were saying. 'I didn't really understand why we couldn't just stay there. The ward didn't seem busy, and Theo just wanted to sleep. 'Theo slept in my bed that night and was restless. I didn't sleep a wink because I was worried about him. We slept with the quilt off as he was still feeling warm. 'I remembered that the doctor had said that Theo might get worse before he got better, so I was thinking that it was his body fighting the infection. 'I was watching my son deteriorate and just thinking that this was how things were supposed to happen, that he would get worse before he got better, but really, he was dying. 'I didn't take his temperature again, but I could tell that he was still warm.' That evening Ms Kenneford phoned the number on the hospital discharge letter and spoke with a nurse but 'felt like I'd been fobbed off'. She then phoned for an ambulance and Theo was taken back to Derriford Hospital where he died in the early hours of July 8. The inquest heard Theo had died sepsis which had been caused by an 'invasive' Strep A infection. The inquest before a jury at County Hall in Exeter continues.
The Independent
2 hours ago
- The Independent
Father's age may impact the success of an IVF pregnancy
A new international study indicates that a father's age plays a crucial and independent role in fertility outcomes, particularly in IVF. The research found that IVF cycles involving male partners over the age of 45 carry significantly increased miscarriage risks and lower live birth rates. The study analysed 1,712 IVF cases between 2019 and 2023 in Italy and Spain, using fresh donor oocytes from younger women. For older prospective fathers, the miscarriage rate reached 23.8 per cent compared to 16.3 per cent in the younger paternal age group, with live birth rates also lower. The findings challenge the traditional focus solely on maternal age and underscore the need for fertility clinics to inform male patients about the impact of their age on fertility potential. Older fathers linked to 'significantly' higher IVF miscarriage risk
Daily Mail
2 hours ago
- Daily Mail
Newest shocking Ozempic side effect revealed... and users say their lives will never be the same
Blockbuster weight-loss shots may slash migraine days in half for millions of sufferers, a study suggests. Researchers in Italy gave 31 obese adults suffering from chronic or frequent migraines liraglutide, the active ingredient in weight-loss drugs Victoza and Saxenda. After three months, the participants' average number of migraine days dropped from 20 to 11. They also said their migraines were less disabling, meaning they were able to function better at work, school, social settings or around the house. While participants lost a small amount of weight, which has been shown to reduce migraine frequency by lowering inflammation and muscle strain, weight loss likely isn't what reduced migraines. The researchers believe liraglutide alleviates pressure from cerebrospinal fluid, the protective liquid that cushions the brain and spine. Dr Simone Braca, lead study author and neurologist at the University of Naples Federico II, suggests even slight buildups of cerebrospinal fluid can press on veins and nerves in the brain, which could trigger migraines. He suggested targeting cerebrospinal fluid levels could make migraines a thing of the past for the 47million Americans who suffer from them. The above chart shows the average number of migraine days before and after participants started liraglutide Dr Braca told ABC News: 'An increased pressure of the spinal fluid in the brain may be one of the mechanisms underlying migraine. 'And if we target this mechanism, this preliminary evidence suggests that it may be helpful for migraine.' Migraines are a severe form of headache that causes throbbing, pulsing pain, usually on one side of the head. These can last hours or days at a time and be triggered by stress, hormonal fluctuations, sleep issues, foods or drinks, smells, lights, noise and weather changes, among others. About one in seven Americans suffers migraines, but for women, that number is closer to one in five. This may be due to hormones like estrogen and menstrual cycles, as well as certain genes that increase susceptibility. Meanwhile, about one in eight Americans, or 40million, has reported taking a GLP-1 agonist like Victoza or Ozempic - which uses semaglutide as the active ingredient instead of liraglutide - at some point. The new study, published earlier this month in the journal Headache, looked at 31 obese adults who had at least eight headache days per month or were diagnosed with chronic migraine. Chronic migraine, which impacts about 4million Americans, is defined as having at least 15 headache days in a month. Study participants also had to have failed at least two standard migraine medications and have a body mass index (BMI) of at least 30, the threshold for obesity. The vast majority, 26, were female, and the average participant age was 45. They were given a 0.6 milligram dose of liraglutide every day for one week and then a 1.2 milligram dose every day for the remainder of the four weeks. All participants were asked to stay on their current migraine drugs if they took them. Using the patients' self-recorded symptom 'diaries,' the researchers found 15 patients had at least a 50 percent reduction in migraine frequency Seven participants (23 percent) saw their migraines drop by 75 percent, and one patient had no headaches at all after the study. On average, migraine days decreased from 20 to 11, a 42 percent difference. The team also measured each patient's Migraine Disability Assessment Score (MIDAS), which defines how much their migraines can disable them and make them less functional at work, school or home on a given day. A higher score is associated with greater disability. The researchers found MIDAS scores decreased from 60 to 29 on average, a 52 percent difference. Participants on average lost a small amount of weight, but it was not statistically significant. About 42 percent of participants (13) had mild side effects including nausea and constipation, but all of them stayed on the medication. There were several limitations to the study, such as the small sample size and the lack of data on glucose or A1C levels, which are linked to diabetes. The team wrote: 'Future studies, with extended follow-up durations, and higher dose evaluations, are necessary to better understand the long-term tolerability and effectiveness of liraglutide in migraine prevention.'
